Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
about
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.Aberrant regulation of FBW7 in cancer.Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.MicroRNA-27b Enhances the Hepatic Regenerative Properties of Adipose-Derived Mesenchymal Stem CellsWhy (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.Similar, not the same: diverse roles and regulation of cyclin Es.Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cellsCombinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.Differences in regulation and function of E-cyclins in human cancer cells.
P2860
Q33660573-E2B72518-89BA-44CA-920F-FD174C22DDEFQ33688508-14E40621-2D90-4E67-BAF4-612C44457E7FQ36189504-AB0E2BA9-8496-4B3F-B1F6-2E52557D908AQ36326335-AD490C23-72D6-4766-83EA-8B9C0AC12553Q36841253-F00D1CD8-E2E6-492C-81CC-3004F8F57B27Q36946187-0E261653-6007-4495-BA77-D5147E5E46B5Q38675849-197537D8-E745-4E31-BAE3-ACB5B0DA0B4BQ38733945-E8C9E930-5FAD-40F2-B461-C07780343561Q39388396-7CDBC9CA-6F05-4829-B15B-33F9C1891C86Q41874772-09CF0AA8-1A7B-460E-A687-C53E40465C32Q42055264-1FC5281A-E815-4504-9257-D61A283D89ABQ42141831-6FFE34BE-03CC-41E7-8A06-BA385BC4AD2C
P2860
Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@ast
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@en
type
label
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@ast
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@en
prefLabel
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@ast
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Differences in degradation lea ...... and cyclin E2 in cancer cells.
@en
P2093
C Elizabeth Caldon
C Marcelo Sergio
Elizabeth A Musgrove
Robert L Sutherland
P2860
P304
P356
10.4161/CC.23409
P577
2013-01-16T00:00:00Z